Shariff, Bushra Barnett, Reagan Dayyani, Farshid Maron, Steven Mcgriskin, Rory Klempner, Samuel Donderici, Elifnur Zhang, Nicole Masannat, Jude Drusbosky, Leylah
...
PURPOSE: In addition to the existing biomarkers HER2 and PD-L1, FGFR2b has become an area of interest for the development of new targeted-based treatment. Given that clinical evaluation of FGFR2 targeted therapy is underway, we sought to elucidate the genomic landscape of FGFR2amp in gastroesophageal cancer (GEC) using a circulating tumor DNA (ctDN...
Wainberg, Zev Kang, Yoon-Koo Lee, Keun-Wook Qin, Shukui Yamaguchi, Kensei Kim, In-Ho Saeed, Anwaar Oh, Sang Li, Jin Turk, Haci
...
BACKGROUND: We report the final results of the randomized phase 2 FIGHT trial that evaluated bemarituzumab, a humanized monoclonal antibody selective for fibroblast growth factor receptor 2b (FGFR2b), plus mFOLFOX6 in patients with FGFR2b-positive (2 + /3 + membranous staining by immunohistochemistry), HER-2-negative gastric or gastroesophageal jun...
Darbellay, Fabrice Ramisch, Anna Lopez-Delisle, Lucille Kosicki, Michael Rauseo, Antonella Jouini, Zahra Visel, Axel Andrey, Guillaume
Chondrocyte differentiation controls skeleton development and stature. Here we provide a comprehensive map of chondrocyte-specific enhancers and show that they provide a mechanistic framework through which non-coding genetic variants can influence skeletal development and human stature. Working with fetal chondrocytes isolated from mice bearing a C...
Goyal, Lipika Meric-Bernstam, Funda Hollebecque, Antoine Valle, Juan Morizane, Chigusa Karasic, Thomas Abrams, Thomas Furuse, Junji Kelley, Robin Cassier, Philippe
...
WHAT IS THIS SUMMARY ABOUT?: This summary describes the results from a phase 2 study called FOENIXCCA2. The study evaluated treatment with futibatinib in people with a rare form of advanced bile duct cancer called intrahepatic cholangiocarcinoma (or iCCA), where the tumors have changes in the structure of a gene called FGFR2. These changes include ...
Wang, Clark G Peiris, Malalage N Meyer, April N Nelson, Katelyn N Donoghue, Daniel J
FGFR3-TACC3 represents an oncogenic fusion protein frequently identified in glioblastoma, lung cancer, bladder cancer, oral cancer, head and neck squamous cell carcinoma, gallbladder cancer, and cervical cancer. Various exon breakpoints of FGFR3-TACC3 have been identified in cancers; these were analyzed to determine the minimum contribution of TACC...
Gabler, Lisa Jaunecker, Carola Nadine Katz, Sonja van Schoonhoven, Sushilla Englinger, Bernhard Pirker, Christine Mohr, Thomas Vician, Petra Stojanovic, Mirjana Woitzuck, Valentin
...
Glioblastoma (GBM) is characterized by a particularly invasive phenotype, supported by oncogenic signals from the fibroblast growth factor (FGF)/ FGF receptor (FGFR) network. However, a possible role of FGFR4 remained elusive so far. Several transcriptomic glioma datasets were analyzed. An extended panel of primary surgical specimen-derived and imm...
Truong, Anh Duc Tran, Ha Thi Thanh Chu, Nhu Thi Nguyen, Huyen Thi Vu, Hao Thi Hong, Yeojin Song, Ki-Duk Dang, Hoang Vu Hong, Yeong Ho
Published in
Animal bioscience
Fibroblast growth factors (FGFs) play critical roles in embryo development, and immune responses to infectious diseases. In this study, to investigate the roles of FGFs, we performed genome-wide identification, expression, and functional analyses of FGF family members in chickens. Chicken FGFs genes were identified and analyzed by using bioinformat...
Qiu, Han Song, Erfei Hu, Yue Li, Tengfei Ku, Kam Ching Wang, Cunchuan Cheung, Bernard M Y Cheong, Lai Yee Wang, Qin Wu, Xiaoping
...
Published in
Cellular and molecular gastroenterology and hepatology
The prevalence of nonalcoholic fatty liver disease (NAFLD) has reached epidemic proportions globally as a result of the rapid increase in obesity. However, there is no Food and Drug Administration-approved pharmacotherapy available for NAFLD. This study investigated the role of autotaxin, a secreted enzyme that hydrolyzes lysophosphatidylcholine to...
Ogura, Koichi Elkrief, Arielle Bowman, Anita S Koche, Richard P de Stanchina, Elisa Benayed, Ryma Mauguen, Audrey Mattar, Marissa S Khodos, Inna Meyers, Paul A
...
PurposeEwing sarcoma (ES) is a primitive sarcoma defined by EWSR1-ETS fusions as the primary driver alteration. To better define the landscape of cooperating secondary genetic alterations in ES, we analyzed clinical genomic profiling data of 113 patients with ES, a cohort including more adult patients (> 18 years) and more patients with advanced st...
Nguyen, Khoa Keith, Madison Keysar, Stephen Hall, Spencer Bimali, Anamol Jimeno, Antonio Wang, Xiao-Jing Young, Christian
Head and neck squamous cell carcinoma (HNSCC) is commonly associated with tobacco and alcohol consumption that induce a precancerous field, with phosphoinositide 3-kinase (PI3K) signaling being a common driver. However, the preclinical effectiveness of PI3K inhibitors has not necessarily translated to remarkable benefit in HNSCC patients. Thus, we ...